Results 11 to 20 of about 78,778 (305)

CD38 (CD38 molecule) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2012
Review on CD38 (CD38 molecule), with data on DNA, on the protein encoded, and where the gene is implicated.
Deaglio, S, Vaisitti, T
openaire   +4 more sources

Double CD38–/CD138– negative multiple myeloma

open access: yesHematology/Oncology and Stem Cell Therapy, 2017
The standard diagnosis of multiple myeloma by flow cytometry is based on selection of population of CD38+/CD138+ positives cells. As the result treatment with proteasome inhibitors, CD138 may be underexpressed on atypical plasma cells.
Vitaliy Mykytiv   +2 more
doaj   +2 more sources

scH16S-Seq Maps Klebsiella pneumoniae-Associated Myeloid States and Reveals a CD38-NAD Immunometabolic Axis That Impairs Lysosomal Acidification in Sepsis. [PDF]

open access: yesAdv Sci (Weinh)
Single‐cell host–bacterial 16S co‐sequencing (scH16S‐seq) integrates cell‐associated bacterial 16S‐derived signals with host transcriptomes to resolve bacterial signal‐enriched myeloid states in Klebsiella pneumoniae sepsis. Complementary pharmacological and genetic analyses define a CD38–NAD immunometabolic axis connecting mitochondrial bioenergetic ...
Li Y   +15 more
europepmc   +2 more sources

CD38 in Advanced Prostate Cancers [PDF]

open access: yes, 2021
BACKGROUND: CD38, a druggable ectoenzyme, is involved in the generation of adenosine, which is implicated in tumour immune evasion. Its expression and role in prostate tumour-infiltrating immune cells (TIICs) have not been elucidated.
Pereira, R   +22 more
core   +4 more sources

Expanding anti-CD38 immunotherapy for lymphoid malignancies [PDF]

open access: yes, 2022
BACKGROUND: Lymphoid neoplasms, including multiple myeloma (MM), non-Hodgkin lymphoma (NHL), and NK/T cell neoplasms, are a major cause of blood cancer morbidity and mortality.
Wang, Xu   +20 more
core   +1 more source

Jujuboside a improved energy metabolism in senescent H9c2 cells injured by ischemia, hypoxia, and reperfusion through the CD38/Silent mating type information regulation 2 homolog 3 signaling pathway

open access: yesWorld Journal of Traditional Chinese Medicine, 2023
Objective: This study explored the myocardial protection role of Jujuboside A through an ischemia–hypoxia–reperfusion (IHR) model. Materials and Methods: H9c2 cells were induced by D-galactose (D-gal) and IHR to establish an aging and IHR model.
Yi-Ran Hu   +4 more
doaj   +1 more source

Bone Marrow Macrophage STING Signaling is a Direct Nexus Linking Marrow Adipose Expansion to NAD+ Depletion and Osteogenic Decline in Skeletal Aging [PDF]

open access: yesAdvanced science
This study reveals that during skeletal aging, bone marrow adipocyte‐derived sDPP4 primes STING signaling in macrophages. In combination with mitochondrial DNA, this signaling activates CD38 and depletes local NAD+/NMN, thereby impairing osteogenesis.
Li Z   +12 more
europepmc   +2 more sources

Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activityResearch in context [PDF]

open access: yes, 2023
Summary: Background: HexaBody®-CD38 (GEN3014) is a hexamerization-enhanced human IgG1 that binds CD38 with high affinity. The E430G mutation in its Fc domain facilitates the natural process of antibody hexamer formation upon binding to the cell surface,
Maarten L. Janmaat   +39 more
core   +1 more source

The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia

open access: yesBiomedical Papers, 2021
Knowledge on acute myeloid leukemia pathogenesis and treatment has progressed recently, but not enough to provide ideal management. Improving the prognosis of acute myeloid leukemia patients depends on advances in molecular biology for the detection of ...
Romeo Gabriel Mihaila, Diana Topircean
doaj   +1 more source

CD38-Directed Vincristine Nanotherapy for Acute Lymphoblastic Leukemia

open access: yes, 2021
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Although intensive chemotherapy greatly improved the survival rate, it is often accompanied by severe and lifelong side effects as a result of weak ALL selectivity.
Jinping Zhang (461246)   +23 more
core   +1 more source

Home - About - Disclaimer - Privacy